Preventing colorectal cancer: early detection leads to healthier employees
Even though colorectal cancer (CRC) is a treatable disease, it is still the second most common cause of cancer deaths in the United States for men and women combined.1 If caught early, in a localized stage, the 5-year survival rate is over 90%. However, only 4 of 10 cases of CRC are found at this stage, and lack of screening compliance is largely to blame.2
One-third of adults aged 45+ have not been screened as guidelines recommend.2
Even though a colonoscopy is the “gold standard” of CRC screening, it is not the only option. The most important fact is that everyone aged 45 and older is screened at regular intervals. One of the least invasive, most convenient screenings is the Fecal Immunochemical Test (FIT), which the American Cancer Society recommends be completed each year.3
Benefits of the FIT for colorectal cancer screenings
FIT screenings, like InSure®ONE™ from Quest Diagnostics, are a cost-effective way for employers to improve screening compliance among employees who qualify for screening based on age. Key benefits of screening with InSureONE include:
- Screening kits mailed directly to eligible employees
- Convenient at-home self-collection
- No need for dietary or medication preparation
- A water-based collection method, meaning no fecal handling, poking, or smearing is needed
- Proven clinical accuracy
Plus, Quest Diagnostics manages the entire program for employers, from contracting and kit mailing to aggregate reporting.
To learn more about adding this gap-in-care solution to your suite of well-being programs, contact us.
- American Cancer Society. Key statistics for colorectal cancer. January 24, 2019. Accessed December 27, 2019.
- American Cancer Society. Can colorectal polyps and cancer be found early? February 21, 2018. Accessed December 27, 2019.
- American Cancer Society. Guideline for colorectal cancer screening. February 21, 2018. Accessed March 2, 2020.